- $22.33m
- -$8.09m
- $8.98m
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies
InspireMD rises after quarterly revenue beat
InspireMD Q4 revenue rises 62%, beats estimates
Brief: InspireMD Provides Notice Of Dismissal To COO Andrea Tommasoli On Feb 27, 2026 - SEC Filing
InspireMD Q3 revenue beats estimates on commercial launch of CGuard Prime
Brief: InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Brief: InspireMD Announces The Appointment Of Dan Dearen To Its Board Of Directors
InspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
Stent maker InspireMD's Q2 revenue beats estimates
Brief: Rxsight, Inc. Appoints Raymond W. Cohen To Its Board Of Directors
InspireMD Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: InspireMD Announces The Appointment Of Raymond W. Cohen To Its Board Of Directors
Brief: InspireMD Inc - Raises $58 Million Through Pipe Financing And Warrants
Brief: InspireMD Says FDA Approval Triggers Second Warrant Tranche In $113.6 Million Financing